» Articles » PMID: 28534083

Synthetic Alpha-synuclein Fibrils Cause Mitochondrial Impairment and Selective Dopamine Neurodegeneration in Part Via INOS-mediated Nitric Oxide Production

Overview
Publisher Springer
Specialty Biology
Date 2017 May 24
PMID 28534083
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Intracellular accumulation of α-synuclein (α-syn) are hallmarks of synucleinopathies, including Parkinson's disease (PD). Exogenous addition of preformed α-syn fibrils (PFFs) into primary hippocampal neurons induced α-syn aggregation and accumulation. Likewise, intrastriatal inoculation of PFFs into mice and non-human primates generates Lewy bodies and Lewy neurites associated with PD-like neurodegeneration. Herein, we investigate the putative effects of synthetic human PFFs on cultured rat ventral midbrain dopamine (DA) neurons. A time- and dose-dependent accumulation of α-syn was observed following PFFs exposure that also underwent phosphorylation at serine 129. PFFs treatment decreased the expression levels of synaptic proteins, caused alterations in axonal transport-related proteins, and increased H2AX Ser139 phosphorylation. Mitochondrial impairment (including modulation of mitochondrial dynamics-associated protein content), enhanced oxidative stress, and an inflammatory response were also detected in our experimental paradigm. In attempt to unravel a potential molecular mechanism of PFFs neurotoxicity, the expression of inducible nitric oxide synthase was blocked; a significant decline in protein nitration levels and protection against PFFs-induced DA neuron death were observed. Combined exposure to PFFs and rotenone resulted in an additive toxicity. Strikingly, many of the harmful effects found were more prominent in DA rather than non-DA neurons, suggestive of higher susceptibility to degenerate. These findings provide new insights into the role of α-syn in the pathogenesis of PD and could represent a novel and valuable model to study DA-related neurodegeneration.

Citing Articles

Female mice exhibit resistance to disease progression despite early pathology in a transgenic mouse model inoculated with alpha-synuclein fibrils.

Tullo S, Park J, Gallino D, Park M, Mar K, Novikov V Commun Biol. 2025; 8(1):288.

PMID: 39987244 PMC: 11846974. DOI: 10.1038/s42003-025-07680-1.


Nitric Oxide in Parkinson's Disease: The Potential Role of Dietary Nitrate in Enhancing Cognitive and Motor Health via the Nitrate-Nitrite-Nitric Oxide Pathway.

Tripodi G, Lombardo M, Kerav S, Aiello G, Baldelli S Nutrients. 2025; 17(3).

PMID: 39940251 PMC: 11819985. DOI: 10.3390/nu17030393.


Alpha Synuclein Toxicity and Non-Motor Parkinson's.

Mazzotta G, Conte C Cells. 2024; 13(15.

PMID: 39120295 PMC: 11311369. DOI: 10.3390/cells13151265.


Positron Emission Tomography with [F]ROStrace Reveals Progressive Elevations in Oxidative Stress in a Mouse Model of Alpha-Synucleinopathy.

Gallagher E, Hou C, Zhu Y, Hsieh C, Lee H, Li S Int J Mol Sci. 2024; 25(9).

PMID: 38732162 PMC: 11084161. DOI: 10.3390/ijms25094943.


Effects of dietary energy level on antioxidant capability, immune function and rectal microbiota in late gestation donkeys.

Guo Y, Yin G, Hui F, Guo X, Shi B, Zhao Y Front Microbiol. 2024; 15:1308171.

PMID: 38414765 PMC: 10896733. DOI: 10.3389/fmicb.2024.1308171.


References
1.
Venda L, Cragg S, Buchman V, Wade-Martins R . α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci. 2010; 33(12):559-68. PMC: 3631137. DOI: 10.1016/j.tins.2010.09.004. View

2.
Luk K, Song C, OBrien P, Stieber A, Branch J, Brunden K . Exogenous alpha-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells. Proc Natl Acad Sci U S A. 2009; 106(47):20051-6. PMC: 2785290. DOI: 10.1073/pnas.0908005106. View

3.
Anderson J, Walker D, Goldstein J, de Laat R, Banducci K, Caccavello R . Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006; 281(40):29739-52. DOI: 10.1074/jbc.M600933200. View

4.
Galvin J, Uryu K, Lee V, Trojanowski J . Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A. 1999; 96(23):13450-5. PMC: 23968. DOI: 10.1073/pnas.96.23.13450. View

5.
Burre J, Sharma M, Tsetsenis T, Buchman V, Etherton M, Sudhof T . Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010; 329(5999):1663-7. PMC: 3235365. DOI: 10.1126/science.1195227. View